Category: Enumeral Bio

Enumeral Biomedical – Platform Validation On Multiple Fronts

Enumeral Biomedical Holdings, Inc. (ENUM) is a development stage biotech company with a focus on immunotherapy for cancer and inflammatory disease. The company has developed a proprietary platform technology with the ability to screen antibodies at a single cell level, which holds multiple advantages over existing technologies. Based on this platform technology, Enumeral is currently…